ARCHIVES

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

This article is from The Cancer Letter archive.

Vol. 40 No. 33 | September 5, 2014

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Says In Business

January 26, 1979

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

NCI Awards 41.5 Million for DES Study

February 28, 1975